0001235802-21-000098.txt : 20210816 0001235802-21-000098.hdr.sgml : 20210816 20210816161926 ACCESSION NUMBER: 0001235802-21-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210816 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pauls Dietrich John CENTRAL INDEX KEY: 0001760123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 211178510 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-08-16 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001760123 Pauls Dietrich John TWO CARLSON PARKWAY, SUITE 260 MINNEAPOLIS MN 55447 1 1 0 0 President and CEO Voting Common Shares, no par value per share 2021-08-16 4 P 0 5000 3.14 A 35804 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.12 to $3.15, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan. /s/ Amy Culbert, attorney-in-fact 2021-08-16